A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
Trial details
- Registry ID
- NCT07038876
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaNCT07038876 | MapLight Therapeutics | Phase 2 | Completed | 2026-06-04Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |